Live coverage: A delegation from multiple countries visited Shandong Jinyang Biopharmaceutical Co.,Ltd

        Live coverage: A delegation from multiple countries visited Shandong Jinyang  Biopharmaceutical Co.,Ltd

Recently, a delegation of 15 people from Germany, Russia, Iran, Tajikistan and Hainan Fippharma Group visited our company for exchange and negotiation. They also held a discussion on further promoting all-round and multi-level cooperation and other matters. General Manager Zhang Hao of  Shandong Jinyang Biological Pharmaceutical Co., Ltd. led the company's senior executives and relevant responsible persons to warmly host them.   

The delegation from Germany, Russia, Iran, Tajikistan and Hainan Fipharm Group first visited the Yuqi Valley Park, the first-phase production workshop and quality inspection center of Shandong Jinyang Biological pharmaceutical Co.,Ltd, etc., and observed the entire production process of Shandong Jinyang Biological pharmaceutical Co.,Ltd products on the spot. The production lines of Jinyang , including the final sterilization of large-volume non-intravenous injections and small-volume injections (including traditional Chinese medicine extraction), are highly efficient, stable, safe and reliable throughout the process. They fully demonstrate the outstanding performance of intelligent production and have won unanimous praise from the visiting team. Vice General Manager Song Xue ning and Vice General Manager Ming Xu gave a detailed explanation of the production processes and procedures of injections, oral liquids and powders to the guests, further enhancing the visiting group's understanding and knowledge of injectable animal health products. 

Late, the visiting group went to the product display cabinet and gained a comprehensive understanding of the full range of products of Shandong Jinyang Biological Pharmaceutical. The company's leaders gave a detailed introduction on the spot, pointing out the significant advantages of Jinyang Biological's products in terms of medication safety, environmental protection performance and operational convenience, and expressed that in the future, they will continue to provide users with more abundant, safer and more efficient clinical aseptic drug dispensing solutions. 

                                                                   Live coverage: Ongoing discussion and exchange...

During the discussion and exchange session, Vice President Song Xuening first extended a warm welcome to the visiting delegation and systematically introduced the progress made by Jinyang Biopharmaceutical in product research and development, technological innovation and market layout. General Manager Zhang Hao stated that Jinyang Biopharmaceutical is a research-oriented production enterprise specializing in serving large-scale breeding enterprises and China's large-scale breeding industry. It was initiated and established by Hainan Yuqi Pharmaceutical Co., Ltd. and is dedicated to the research and development, production of animal drugs, disinfectants, and feed additives. He hopes that this exchange will serve as an opportunity to deepen strategic cooperation with the visiting delegation, integrate resource advantages, and jointly promote the high-quality development of animal husbandry. During the interactive session, both sides engaged in extensive and in-depth discussions on topics such as the development trends of the livestock market, product channel circulation, and technological innovation. They proposed multiple cooperation ideas and reached preliminary consensus in many aspects. This visit and exchange not only deepened the mutual understanding between the two sides but also laid a solid foundation for future cooperation. Jinyang Biopharmaceutical has always embraced industry partners with a win-win attitude, looking forward to deepening collaboration with a wide range of customers and partners to jointly write a new chapter in the upgrading of the livestock and animal health industry!

                                                                                 ABOUT US   

Shandong Jinyang Biological Pharmaceutical Co., Ltd. was initiated and established by Hainan Yuqi Pharmaceutical Co., LTD. It is a high-tech enterprise specializing in the production and research and development of veterinary drugs. It not only provides professional technical support and services for the breeding industry, but also brings a variety of high-quality products to the field of pet health and care. Shandong Jinyang Biological Pharmaceutical Co., Ltd. has passed the GMP certification of the Ministry of Agriculture and Rural Affairs for six production lines, including powder/premix, powder, final sterilized large-volume non-intravenous injection, final sterilized small-volume injection (including traditional Chinese medicine extraction), oral solution (including traditional Chinese medicine extraction), and disinfectant (liquid, grade D). Mr. Yin Shengzhang, the chairman of Hainan Yuqi Pharmaceutical Co., LTD., concurrently serves as the R&D director of Shandong Jinyang Biological Pharmaceutical Co., LTD., responsible for the research and development of new products and the improvement of production processes of the company. Mr. Yin Shengzhang, a Doctor of Biology, is a veterinary researcher specializing in the research and development and manufacturing of veterinary drugs as well as the study of drugs for swine infectious diseases. He served as a member of the third, fourth and fifth expert committees of the National Veterinary Drug Pharmacopoeia Committee of China. He was the first in China to develop raw materials and preparations of enrofloxacin, florfenicol, diflufloxacin, salafloxacin, ceftiofuran, sulfamethoxine and roxarsine, and was among the first to obtain new drug certificates. He also presided over the research and development of projects such as macromolecular antibiotics, tylamectin, tofinamic acid, butaphosphorus, tobutylphosphorus raw materials and preparations, meloxicam injection, and the extraction process of traditional Chinese medicine by biological enzymes. Moreover, he introduced mathematical graph theory, multivariate analysis methods, and nonlinear programming models under constraints into the selection and optimization of synthetic processes and the screening of formulation prescriptions.  

Address: No. 3311, Heitieshan Road, High-tech Zone, Zibo City 

Email: jinyangbio@163.com 

Tel: 0533-7920666 

Fax: 0533-7920666